z-logo
Premium
Variability in Renal Clearance of Substrates for Renal Transporters in Chinese Subjects
Author(s) -
Yin Ophelia Q. P.,
Tomlinson Brian,
Chow Moses S. S.
Publication year - 2006
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1177/0091270005283838
Subject(s) - renal function , famotidine , bioequivalence , organic anion transporter 1 , metformin , population , chinese population , pharmacology , chemistry , transporter , medicine , pharmacokinetics , biochemistry , genotype , environmental health , insulin , gene
The authors evaluated the inter‐ and intraindividual variability in the renal clearance of substrates of organic anion transporters (OAT) or organic cation transporters (OCT) using repeated drug application procedures. Two OAT substrates (ampicillin and cephalexin) and 2 OCT substrates (famotidine and metformin) were selected. Each drug was administered orally twice to healthy subjects, with sample sizes ranging from 12 to 28 (using bioequivalent formulations of each drug). The inter‐ (δ inter ) and intrasubject (δ intra ) variances in renal clearance were estimated based on analysis of variance, and the genetic contribution (r GC ) was calculated as (δ inter ‐ intra )/δ inter . The renal clearances of ampicillin, cephalexin, famotidine, and metformin averaged 5.21 (range, 2.87–11.20), 3.01 (range, 1.50–3.82), 4.96 (range, 2.84–8.17), and 9.44 (range, 5.66–15.43) mL/min/kg, with mean intraindividual coefficients of variation of 17.7%, 7.3%, 13.5%, and 9.0% and r GC values of 0.75, 0.89, 0.81, and 0.93, respectively. These high r GC values suggest a potential significant genetic contribution by the renal OATs and OCTs in Chinese subjects. Further studies in a larger population are needed to confirm the importance of these results as well as to identify specific genetic variants in these transporters responsible for such variability.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here